Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Arcturus Therapeutics Holdings (ARCT) Other Non-Current Assets (2018 - 2025)

Arcturus Therapeutics Holdings' Other Non-Current Assets history spans 8 years, with the latest figure at $1.9 million for Q4 2025.

  • For Q4 2025, Other Non-Current Assets changed 0.0% year-over-year to $1.9 million; the TTM value through Dec 2025 reached $1.9 million, changed 0.0%, while the annual FY2025 figure was $1.9 million, 0.0% changed from the prior year.
  • Other Non-Current Assets reached $1.9 million in Q4 2025 per ARCT's latest filing, roughly flat from $1.9 million in the prior quarter.
  • In the past five years, Other Non-Current Assets ranged from a high of $22.1 million in Q3 2023 to a low of $107000.0 in Q1 2021.
  • Average Other Non-Current Assets over 5 years is $3.6 million, with a median of $2.0 million recorded in 2021.
  • Peak YoY movement for Other Non-Current Assets: surged 1977.0% in 2021, then plummeted 91.48% in 2024.
  • A 5-year view of Other Non-Current Assets shows it stood at $2.1 million in 2021, then rose by 0.82% to $2.1 million in 2022, then dropped by 9.98% to $1.9 million in 2023, then changed by 0.0% to $1.9 million in 2024, then changed by 0.0% to $1.9 million in 2025.
  • Per Business Quant, the three most recent readings for ARCT's Other Non-Current Assets are $1.9 million (Q4 2025), $1.9 million (Q3 2025), and $1.9 million (Q2 2025).